Navigation Links
Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial
Date:5/29/2008

WOODCLIFF LAKE, N.J., May 29 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that its development partner, Alfacell Corporation (Nasdaq: ACEL) reported that the preliminary statistical analysis of data from its confirmatory Phase IIIb clinical trial of its lead compound, ONCONASE (ranpirnase), did not meet statistical significance for the primary endpoint of survival in unresectable malignant mesothelioma (UMM). However, a statistically significant improvement in survival was seen in the treatment of UMM patients who failed one prior chemotherapy regimen.

The preliminary results are based on 320 evaluable events that occurred in the clinical trial out of a total of 428 patients randomized. The trial was designed to show a statistically significant improvement in overall survival (p < 0.048) for UMM patients who were treated with a combination of ONCONASE plus doxorubicin as compared to patients who were treated with doxorubicin as a single agent. The analysis of the data did not show a statistically significant improvement for evaluable patients receiving ONCONASE plus doxorubicin (unadjusted log rank p=0.80). The median survival time (MST) for evaluable patients who received ONCONASE plus doxorubicin was 11.1 months as compared to 10.7 months for patients who received doxorubicin as a single agent.

Statistically significant results were achieved in evaluable UMM patients who failed a prior chemotherapy
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
2. Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac(TM) Development at Prestigious International Symposium
3. Access Pharmaceuticals Presents New Data on the Companys Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium
4. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
5. QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy
6. Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
7. Tioga Pharmaceuticals Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome
8. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
9. Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day
10. Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute
11. VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... and NEW YORK , July ... a developer of new products for oncology supportive care, ... ® , has been featured in an article on ... Symptoms in Head and Neck Cancers."  Dr. Steve ... insight on the growing demand seen in the oncology ...
(Date:7/30/2014)... LAKE FOREST, Ill., July 30, 2014  Hospira, ... leading provider of injectable drugs and infusion technologies, ... June 30, 2014. Net sales for the quarter ... share were $0.72. (Adjusted* measures exclude specified items ... the attached schedules.) On a U.S. Generally Accepted ...
(Date:7/30/2014)... DIEGO , July 30, 2014   ... biotech company that designs and develops novel diagnostics ... of cancer, announced today the completion of a ... financing included new investors RusnanoMedInvest (RMI) and Arcus ... and Pfizer Venture Investments, as well as undisclosed ...
Breaking Medicine Technology:Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3Hospira Reports Second-Quarter 2014 Results 2Hospira Reports Second-Quarter 2014 Results 3Hospira Reports Second-Quarter 2014 Results 4Hospira Reports Second-Quarter 2014 Results 5Hospira Reports Second-Quarter 2014 Results 6Hospira Reports Second-Quarter 2014 Results 7Hospira Reports Second-Quarter 2014 Results 8Hospira Reports Second-Quarter 2014 Results 9Hospira Reports Second-Quarter 2014 Results 10Hospira Reports Second-Quarter 2014 Results 11Hospira Reports Second-Quarter 2014 Results 12Hospira Reports Second-Quarter 2014 Results 13Hospira Reports Second-Quarter 2014 Results 14Hospira Reports Second-Quarter 2014 Results 15Hospira Reports Second-Quarter 2014 Results 16Hospira Reports Second-Quarter 2014 Results 17Hospira Reports Second-Quarter 2014 Results 18Hospira Reports Second-Quarter 2014 Results 19Hospira Reports Second-Quarter 2014 Results 20Hospira Reports Second-Quarter 2014 Results 21Hospira Reports Second-Quarter 2014 Results 22Hospira Reports Second-Quarter 2014 Results 23Hospira Reports Second-Quarter 2014 Results 24Hospira Reports Second-Quarter 2014 Results 25Hospira Reports Second-Quarter 2014 Results 26Hospira Reports Second-Quarter 2014 Results 27Hospira Reports Second-Quarter 2014 Results 28Hospira Reports Second-Quarter 2014 Results 29Hospira Reports Second-Quarter 2014 Results 30Hospira Reports Second-Quarter 2014 Results 31Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 2Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 3
... announcement today, the University of California Los Angeles (UCLA) ... report the launch of the CLEAR Study , ... Obstructive Pulmonary Disease (COPD).  COPD is a leading and ... Organization, will become the world,s third most common cause ...
... 6, 2012 HeartWare International, Inc. (NASDAQ: HTWR, ASX:HIN) ... results for the three and 12 months ended December ... on Thursday, February 16, 2012 (being midnight Australian Eastern ... The Company plans to release the financial results prior ...
Cached Medicine Technology:ERT and UCLA Initiate Innovative Pilot Program for Chronically Ill Patients 2ERT and UCLA Initiate Innovative Pilot Program for Chronically Ill Patients 3ERT and UCLA Initiate Innovative Pilot Program for Chronically Ill Patients 4HeartWare Schedules Fourth Quarter Conference Call and Webcast 2
(Date:7/31/2014)... latest blog post, Best Drug Rehabilitation , which offers ... a stay in rehab can make a big difference in ... 10 tips to help drug or alcohol addicts cope after ... and one that former addicts and those who support them ... Rehabilitation’s CEO Per Wickstrom . , According to ...
(Date:7/31/2014)... Thanks to its mildly sweet flavor ... been used as a medium for delivery of ... However consistent, dependable sourcing of erythritol often fluctuates. ... and beverage manufacturers’ increasing needs for reliable, dependable, ... ErysweetTM Erythritol. , “Erysweet is unique in ...
(Date:7/31/2014)... 2014 Nuanced Media, a leading digital ... the Nuanced Medical website . Nuanced Medical, and ... of the Medical Industry. , The idea behind Nuanced ... medical practices to meet continuously changing federal regulations. The ... Act (Health Insurance Portability and Accountability Act), which is ...
(Date:7/30/2014)... Calling all runners in the Richmond, VA region. , ... a monthly Runner’s Injury Clinic at the Glen ... second Monday of each month through the end of the ... and December 8. , The clinics run from 5:30 ... shoes and attire, will receive a complimentary evaluation of running ...
(Date:7/30/2014)... July 31, 2014 Responding to ... environment more responsive to an increasingly diverse patient ... experience and scholarly expertise to the publication of ... care professions: "Diversity and Cultural Competence in Health ... L. Dreachslin, PhD, a professor in the Management ...
Breaking Medicine News(10 mins):Health News:New Best Drug Rehabilitation Blog Posts Looks at 10 Tips for Coping After Drug or Alcohol Rehab 2Health News:Steviva Ingredients Launches Erysweet Erythritol 2Health News:Nuanced Media, HIPAA Certified Agency, Launches Medical Web Design Service Website 2Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 2Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 3Health News:NLN CEO Co-Authors Textbook to Advance Diversity and Cultural Competence Across Health Care Professions 2Health News:NLN CEO Co-Authors Textbook to Advance Diversity and Cultural Competence Across Health Care Professions 3
... today that it has reached an agreement to sell ... asset-backed commercial paper (ABCP) with,a book value of $7.0 ... right to receive additional proceeds in the event the,buyer ... event, Westaim,will receive 50 per cent of any proceeds ...
... 26 ALLDATA SHREDDING INC., the leading,Pacific Northwest information ... tomorrow. The closely-held,family-owned and operated company commemorates the following ... zero security breaches. -- An overall performance rating ... & Bradstreet,s Open Ratings. ...
... SINGAPORE, Nov. 26 Flextronics (Nasdaq: FLEX ),today ... Tuesday,January 29, 2008., The earnings conference call, hosted ... PST to discuss the financial results,of the Company for ... earnings call will be available via the Internet and ...
... Computed tomography (CT) angiography is as accurate as an ... the findings of the first two prospective multicenter 64-slice ... the Radiological Society of North America (RSNA). , ... stage for the widespread adoption of and reimbursement for ...
... It may be undertreated compared to white patients, research suggests ... more likely than white women to suffer severe pain linked ... more than 1,100 patients in 19 countries. , The women ... were given a pain test called the Brief Pain Inventory ...
... Mich., Nov. 26 In keeping with its,commitment to ... Care Network of Michigan, a leading HMO in the ... among its own employees at the,workplace., BCN, which ... of,Michigan, earlier this year instituted Wellness Works!, an employee ...
Cached Medicine News:Health News:Westaim reduces ABCP exposure 2Health News:ALLDATA SHREDDING Celebrates Fifth Anniversary With 'A' Grade From Clients 2Health News:Flextronics to Report Third Quarter Results 2Health News:CT angiography highly accurate, multicenter trials show 2Health News:Leading by Example: Blue Care Network of Michigan Shows How Employers Can Improve Employee Wellness 2
... planned ECCE with peristaltic pump with ... suction, reflux possible with multi-function footswitch ... all critical functions. You can also ... actual vacuum level indicated by Bar ...
... Posterior segment surgeries Vitrectomy-Lensectomy + Irrigation/Aspiration ... Peristaltic Linear Aspiration. Interchangeable disposable blades ... action. Easy to read LED display ... from 1- 600 cuts per minute. ...
...
Enables Delicate Lifting Of The Flap Without Causing Trauma - Also available in Titanium...
Medicine Products: